India needs innovation-led pharma industry: Kiran Mazumdar-Shaw
Biocon’s Kiran Mazumdar-Shaw urges India to move beyond generics and build an innovation-led pharma industry by boosting research, speeding up regulatory approvals, and sustaining investment in new drug development to compete globally. India must move beyond its success in generic medicines and build an innovation-led pharmaceutical industry by strengthening research, speeding up regulatory approvals and … Read more